Palvella Therapeutics (PVLA) Revenue (2014 - 2024)
Palvella Therapeutics (PVLA) reported Revenue of $53000.0 for Q1 2024, down 97.26% year-over-year from $1.9 million in Q2 2023, and down 99.66% quarter-over-quarter from $15.6 million in Q3 2023.
Palvella Therapeutics (PVLA) Revenue (2014 - 2024) Analysis & Trends
Palvella Therapeutics (PVLA) has 11 years of Revenue data on file, last reported at $53000.0 in Q1 2024.
- Revenue for Q1 2024 came in at $53000.0, down 97.26% year-over-year; the trailing twelve-month figure through Sep 2024 was $15.6 million (down 58.69% YoY), and the FY2021 annual result was $27.9 million, down 4.72% from the prior year.
- Revenue eased to $53000.0 in Q1 2024 per PVLA's latest filing, from $15.6 million in the prior quarter.
- Over five years, Revenue peaked at $20.1 million in Q2 2023 and troughed at $53000.0 in Q1 2024.
- A 5-year average of $7.0 million and a median of $3.5 million in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2024: Revenue soared 5934.5% in 2023, then tumbled 97.26% in 2024.
- A 5-year view of Revenue shows it stood at $1.9 million in 2020, then jumped by 164.52% to $5.0 million in 2021, then sank by 94.8% to $258000.0 in 2022, then soared by 5934.5% to $15.6 million in 2023, then sank by 99.66% to $53000.0 in 2024.
- Business Quant data shows PVLA's Revenue at $53000.0 in Q1 2024, $15.6 million in Q3 2023, and $20.1 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 53,000.00 |
| Sep 30, 2023 | 15.57 Mn |
| Jun 30, 2023 | 20.06 Mn |
| Mar 31, 2023 | 1.94 Mn |
| Sep 30, 2022 | 258,000.00 |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 10.99 Mn |
| Dec 31, 2021 | 4.97 Mn |
| Sep 30, 2021 | 2.78 Mn |
| Jun 30, 2021 | 2.54 Mn |
| Mar 31, 2021 | 13.00 Mn |
| Dec 31, 2020 | 1.88 Mn |
| Sep 30, 2020 | 2.94 Mn |
| Jun 30, 2020 | 11.25 Mn |
| Mar 31, 2020 | 13.26 Mn |
| Dec 31, 2019 | 3.06 Mn |
| Sep 30, 2019 | 15.13 Mn |
| Jun 30, 2019 | 5.33 Mn |
| Mar 31, 2019 | 8.55 Mn |
| Dec 31, 2018 | 600,000.00 |